176 related articles for article (PubMed ID: 35499557)
1. Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma.
Aragon-Sanabria V; Aditya A; Zhang L; Chen F; Yoo B; Cao T; Madajewski B; Lee R; Turker MZ; Ma K; Monette S; Chen P; Wu J; Ruan S; Overholtzer M; Zanzonico P; Rudin CM; Brennan C; Wiesner U; Bradbury MS
Clin Cancer Res; 2022 Jul; 28(13):2938-2952. PubMed ID: 35499557
[TBL] [Abstract][Full Text] [Related]
2. Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model.
Juthani R; Madajewski B; Yoo B; Zhang L; Chen PM; Chen F; Turker MZ; Ma K; Overholtzer M; Longo VA; Carlin S; Aragon-Sanabria V; Huse J; Gonen M; Zanzonico P; Rudin CM; Wiesner U; Bradbury MS; Brennan CW
Clin Cancer Res; 2020 Jan; 26(1):147-158. PubMed ID: 31515460
[TBL] [Abstract][Full Text] [Related]
3. Molecular Engineering of Ultrasmall Silica Nanoparticle-Drug Conjugates as Lung Cancer Therapeutics.
Madajewski B; Chen F; Yoo B; Turker MZ; Ma K; Zhang L; Chen PM; Juthani R; Aragon-Sanabria V; Gonen M; Rudin CM; Wiesner U; Bradbury MS; Brennan C
Clin Cancer Res; 2020 Oct; 26(20):5424-5437. PubMed ID: 32723835
[TBL] [Abstract][Full Text] [Related]
4. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
5. Targeted melanoma radiotherapy using ultrasmall
Zhang X; Chen F; Turker MZ; Ma K; Zanzonico P; Gallazzi F; Shah MA; Prater AR; Wiesner U; Bradbury MS; McDevitt MR; Quinn TP
Biomaterials; 2020 May; 241():119858. PubMed ID: 32120314
[TBL] [Abstract][Full Text] [Related]
6. A Genomic Profile of Local Immunity in the Melanoma Microenvironment Following Treatment with α Particle-Emitting Ultrasmall Silica Nanoparticles.
Urbanska AM; Khanin R; Alidori S; Wong S; Mello BP; Almeida BA; Chen F; Ma K; Turker MZ; Korontsvit T; Scheinberg DA; Zanzonico PB; Wiesner U; Bradbury MS; Quinn TP; McDevitt MR
Cancer Biother Radiopharm; 2020 Aug; 35(6):459-473. PubMed ID: 32013538
[TBL] [Abstract][Full Text] [Related]
7. Ultrasmall PEGylated and Targeted Core-Shell Silica Nanoparticles Carrying Methylene Blue Photosensitizer.
Kohle FFE; Li S; Turker MZ; Wiesner UB
ACS Biomater Sci Eng; 2020 Jan; 6(1):256-264. PubMed ID: 33463188
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
9. Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment.
Liu CM; Chen GB; Chen HH; Zhang JB; Li HZ; Sheng MX; Weng WB; Guo SM
Colloids Surf B Biointerfaces; 2019 Mar; 175():477-486. PubMed ID: 30572156
[TBL] [Abstract][Full Text] [Related]
10. Ultrasmall Folate Receptor Alpha Targeted Enzymatically Cleavable Silica Nanoparticle Drug Conjugates Augment Penetration and Therapeutic Efficacy in Models of Cancer.
Wu F; Chen PM; Gardinier TC; Turker MZ; Venkatesan AM; Patel V; Khor T; Bradbury MS; Wiesner UB; Adams GP; Germano G; Chen F; Ma K
ACS Nano; 2022 Dec; 16(12):20021-20033. PubMed ID: 36264003
[TBL] [Abstract][Full Text] [Related]
11. Ultrasmall dual-modality silica nanoparticle drug conjugates: Design, synthesis, and characterization.
Yoo B; Ma K; Zhang L; Burns A; Sequeira S; Mellinghoff I; Brennan C; Wiesner U; Bradbury MS
Bioorg Med Chem; 2015 Nov; 23(22):7119-30. PubMed ID: 26462054
[TBL] [Abstract][Full Text] [Related]
12. Ratiometric delivery of two therapeutic candidates with inherently dissimilar physicochemical property through pH-sensitive core-shell nanoparticles targeting the heterogeneous tumor cells of glioma.
Xu HL; Fan ZL; ZhuGe DL; Tong MQ; Shen BX; Lin MT; Zhu QY; Jin BH; Sohawon Y; Yao Q; Zhao YZ
Drug Deliv; 2018 Nov; 25(1):1302-1318. PubMed ID: 29869524
[TBL] [Abstract][Full Text] [Related]
13. Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma Imaging.
Chen F; Zhang X; Ma K; Madajewski B; Benezra M; Zhang L; Phillips E; Turker MZ; Gallazzi F; Penate-Medina O; Overholtzer M; Pauliah M; Gonen M; Zanzonico P; Wiesner U; Bradbury MS; Quinn TP
ACS Appl Mater Interfaces; 2018 Feb; 10(5):4379-4393. PubMed ID: 29058865
[TBL] [Abstract][Full Text] [Related]
14. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional Polyethylene Glycol (PEG)-Poly (Lactic-Co-Glycolic Acid) (PLGA)-Based Nanoparticles Loading Doxorubicin and Tetrahydrocurcumin for Combined Chemoradiotherapy of Glioma.
Zhang X; Zhao L; Zhai G; Ji J; Liu A
Med Sci Monit; 2019 Dec; 25():9737-9751. PubMed ID: 31856143
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
17. Ultrasmall Renally Clearable Silica Nanoparticles Target Prostate Cancer.
Chen F; Ma K; Zhang L; Madajewski B; Turker MZ; Gallazzi F; Cruickshank K; Zhang X; Jenjitranant P; Touijer KA; Quinn TP; Zanzonico P; Wiesner U; Bradbury MS
ACS Appl Mater Interfaces; 2019 Nov; 11(47):43879-43887. PubMed ID: 31675204
[TBL] [Abstract][Full Text] [Related]
18. Integrin α
Huang CW; Chuang CP; Chen YJ; Wang HY; Lin JJ; Huang CY; Wei KC; Huang FT
J Nanobiotechnology; 2021 Jun; 19(1):180. PubMed ID: 34120610
[TBL] [Abstract][Full Text] [Related]
19. pH-Responsive Core-Shell Structured Nanoparticles for Triple-Stage Targeted Delivery of Doxorubicin to Tumors.
Han L; Tang C; Yin C
ACS Appl Mater Interfaces; 2016 Sep; 8(36):23498-508. PubMed ID: 27558413
[TBL] [Abstract][Full Text] [Related]
20. Closed-loop trans-skull ultrasound hyperthermia leads to improved drug delivery from thermosensitive drugs and promotes changes in vascular transport dynamics in brain tumors.
Kim C; Guo Y; Velalopoulou A; Leisen J; Motamarry A; Ramajayam K; Aryal M; Haemmerich D; Arvanitis CD
Theranostics; 2021; 11(15):7276-7293. PubMed ID: 34158850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
